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ABSTRACT 
  The objective of this study was to determine the effects of various estrous 
synchronization protocols utilizing the five-day controlled internal drug releasing (CIDR) inserts 
that are infused with progesterone (P4) alone and when coupled with gonadotropin-releasing 
hormone (GnRH) and prostaglandin (PG) during different breeding seasons.  Ewes received 
either 1 of 4 treatments: 1) Untreated (U); 2) 5 d CIDR (0.3 g P4) insert (C); 3) 5 d CIDR and 
PG at CIDR removal (d 0, P); or 4) GnRH at 5 d CIDR insertion and PG at CIDR removal (G).  
In Experiment 1, overall days to estrus were greater (P ≤ 0.01) in U and P compared with C.  In 
Experiment 2, overall days to estrus were greater (P ≤ 0.02) in U and P compared with G. In 
summary, the 5 d CIDR reduces the number of days required to bring ewes into estrus when 
compared to untreated ewes. 
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CHAPTER 1. LITERATURE REVIEW 
Introduction 
 One of the largest factors having an impact on today’s sheep industry that will ensure its 
future success and long-term sustainability is reproductive performance.  The United States 
(U.S.) sheep industry is facing an exciting time with lamb and wool prices at an all-time high.  
However, for the U.S. sheep industry to remain competitive and to continue growing to meet the 
needs of consumers, it would be beneficial for producers to employ advanced reproductive 
technologies that improve efficiency and ultimately leading to an increase in their flock 
productivity.  By doing so, producers will be able to enhance their operation’s production in 
terms of percent lamb crop produced by a flock per year (National Research Council, 2008).  To 
do so, a producer may potentially want to begin utilizing controlled internal drug releasing 
(CIDR) inserts, selecting for highly prolific ewes that are capable of breeding out-of-season, 
while culling ewes that don’t produce twins.  
To produce lambs consistently throughout the year in an accelerated lambing system, the 
use of exogenous hormones can be utilized in order to induce a synchronized estrus and 
stimulate cyclicity during the anestrous period.  This can be achieved by either lengthening or 
reducing the duration of the estrous cycle by administration of exogenous progesterone (P4) or 
prostaglandin (PG).  Gonadotropin-releasing hormone (GnRH) may also be incorporated into 
treatment protocols to assist in initiating hormonal events necessary to synchronize estrous 
cycles, such as estrus and ovulation, especially in anestrous ewes (Wildeus, 2000).  
In 2009, the U.S. Food and Drug Administration (FDA) approved the CIDR for 
commercial use in sheep.  The current label recommendation is to insert one CIDR per ewe for 5 
days (d) with the intention of inducing estrus in ewes during the anestrous season (FDA, 2009).  
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Therefore, the P4 inserts are referred to as 5 d CIDRs.  This thesis focuses on examining the 
efficacy of the newly approved 5 d CIDR inserts for use in the commercial sheep industry during 
both the transition and anestrous seasons.  The transition period (August through October) is the 
gradual change from the anestrous to estrous season, whereas the anestrous season (April 
through May) is when breeding typically does not occur.  Prior to approval, common industry 
practice was to insert a CIDR, being used off label from New Zealand, for 12 to 14 d with or 
without an injection of gonadotropin (Rhodes and Nathanielsz, 1988; Carlson et. al, 1989; 
Wildeus, 2000; Abecia and Gonzalez-Bulnes, 2012).   
In two studies by Knights et al. (2001a; 2001b), a 5 d CIDR treatment induced estrus in a 
greater proportion of seasonally anestrous ewes compared with untreated ewes.  Addition of a 
PG injection at CIDR removal elicited a greater percentage of ewes observed in estrus and a 
greater lambing rate to the first service period, three days following CIDR removal, compared 
with ewes treated with PG alone (Dixon et al., 2006).  Moreover, in a recent study, Titi et al. 
(2010) reported improvements in estrous synchronization and prolificacy with the inclusion of an 
injection of GnRH prior to insertion and PG at removal of intravaginal P4 impregnated sponges 
for 5 d during the breeding season.  Limited research has been conducted utilizing the 5 d CIDR 
in combination with GnRH and PG in seasonally anestrous and estrous ewes. 
Therefore, the following research focuses on synchronizing estrus in ewes during both 
the breeding and non-breeding seasons by potentially reducing the days to detected estrus, while 
increasing overall ewe prolificacy through the utilization of various 5 d CIDR protocols that 
include various combinations of the administration of GnRH and PG.         
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Reproduction in the Ewe 
The Estrous Cycle 
A unique characteristic of sheep compared with cattle and swine is that the ovine specie 
is seasonally polyestrous between two distinct periods.  Seasonally polyestrous females exhibit 
numerous estrous cycles that occur repeatedly only during a specific season of the year unless 
interrupted by pregnancy.  A reproductive cycle consisting of predictable events, both behavioral 
changes and ovulation, which presents an opportunity for a female to become pregnant, is 
referred to as the estrous cycle (Senger, 2005).  The estrous cycle begins at estrus and ends at the 
start of the ensuing estrus, lasting on average 17 d (Figure 1.1; Downey, 1980; Rosa and Bryant, 
2003; Bartlewski et al., 2011).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.  An illustrative representation of the changes in hormone levels throughout the 
estrous cycle of the ewe (Adapted from Caldwell et al., 1972).  
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Two major phases comprise the estrous cycle; the follicular and luteal phases which 
represent 20 and 80% of the cycle, respectively.  Each phase can be further divided into two 
stages each, with the follicular phase consisting of proestrus and estrus and the luteal phase 
consisting of metestrus and diestrus (McDonald, 1980).  Follicular dynamics, which is the 
process of follicular growth and degeneration, occurs continually throughout the follicular phase, 
which lasts approximately 2 to 3 d (Gordon, 1997; Senger, 2005).  The stage of proestrus which 
begins after luteolysis or destruction of the corpus luteum (CL) in which P4 levels are declining, 
is characterized by elevated concentrations of estradiol (E2), due to growing follicles that are 
now the dominant ovarian structures.  Release of follicle-stimulating hormone (FSH) from the 
anterior pituitary (AP) is responsible for inducing follicular growth.  Due to elevated 
concentrations of E2, a luteinizing hormone (LH) surge is experienced because of the positive 
feedback of E2 on the hypothalamus which releases a surge of GnRH which acts on the AP thus 
causing a surge of LH and hence ovulation occurs.  The stage of estrus beginning at the cessation 
of proestrus and estrus or ‘heat’, d 0 (Figure 1.1) of the estrous cycle, is the most visible event 
during this time.  Estrus is the most recognizable behavioral change and is characterized by 
standing ‘heat’, a period in which the female is receptive to being bred (McDonald, 1980).  The 
duration of estrus in the ewe typically lasts 30 hours (h) with ovulation occurring at 24 to 30 h 
after the onset of estrus (Downey, 1980; McDonald, 1980; Murdoch, 1985).    
Ovulation brought about by the surge of LH during proestrus and estrus transition the 
ewe into the luteal phase (Gordon, 2004).  The ewe undergoes spontaneous ovulation and 
therefore no cervical or vaginal stimulation is needed to induce ovulation; rather, ovulation is 
under hormonal control (Senger, 2005).  Spanning ovulation and formation of the newly 
developed and functional CL is metestrus, occurring briefly for 2 d.  During this time, E2 
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concentrations are decreasing and the newly ovulated follicle transforms into a CL and P4 
concentrations are increasing quickly.  Production of P4 and increases in concentrations of P4 
are reflective of the growth and development of the CL as it becomes larger through the process 
of luteinization, cellular and structural remodeling.  The last and longest stage (10 to 14 d) to 
occur is diestrus.  Diestrus occurs from the time the CL becomes functional and maximum 
secretion of P4 has been attained until luteolysis, structural and function degradation, of the CL.  
Peak levels of P4 are secreted around d 8 of the estrous cycle and concentrations are maintained 
until d 15 (McDonald, 1980; Gordon, 2004; Senger, 2005).  The P4 being secreted by the CL is 
primarily responsible for regulating LH secretion (Abecia, 2011).  If pregnancy does not occur, 
PG is secreted by the uterus in a pulsatile manner which will then cause regression of the CL.  
Due to a decrease in circulating concentrations of P4 at this time, another follicular phase will 
now be permitted to develop (Figure 1.1).             
Hormonal Control of the Estrous Cycle 
 A variety of hormones are responsible for regulating the estrous cycle, all of which are 
produced primarily from four major systems of organs including the anterior and posterior lobes 
of the pituitary gland, the hypothalamus, ovary, and uterus.  Of these, the hypothalamus plays a 
substantial role in neural regulation of the release of reproductive hormones.  Melatonin 
stimulates the release of GnRH to bring about cyclicity in anestrous ewes (Senger, 2005).  
Gonadotropin-releasing hormone, a neurohormone that is synthesized and stored in the medial 
basal hypothalamus, is a decapeptide consisting of 10 amino acids, and provides the link between 
the neural and endocrine systems (Convey, 1973).  Release of GnRH occurs in two different 
fashions depending on which of the two regions in the hypothalamus GnRH is being secreted.  
Two centers mediate the release of GnRH, the tonic and surge centers.  The tonic center is 
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comprised of the ventromedial nucleus and the arcuate nucleus and is accountable for the basal 
secretion of GnRH.  Through basal secretion, GnRH is released in very small pulses over an 
extended period of time at a constant and basal level.  Through these small pulses of GnRH 
which act upon the anterior pituitary, the release of FSH and LH is stimulated.  The growth and 
development of ovarian follicles are promoted by the stimulation of FSH and LH.  In contrast, 
large doses of GnRH are secreted from the surge center in short bursts of high amplitude and 
frequency pulses.  In order for GnRH to be released from the surge center, E2 concentrations 
must be high and P4 concentrations must be low.  The surge center, is also referred to as the 
preovulatory center because it is responsible for the preovulatory release of GnRH.  This 
preovulatory release of GnRH drives a surge release of LH, thus causing an ovulation (Hafez and 
Hafez, 2000; Senger, 2005). 
 Two glycoproteins released from the anterior pituitary, at or near the onset of estrus, are 
LH and FSH (Pant et al., 1977).  The major luteotropic hormone in the ewe is LH and it is 
responsible for the release of the ovum after the wall of the follicle ruptures, while growth and 
maturation of the Graafian follicle is the primary duty of FSH (Hansel and Convey, 1983).  By 
increasing adenylate cyclase and cyclic AMP (cAMP) the steroidogenic effects elicited by LH 
are able to be carried out on luteal tissues (Hansel and Convey, 1983).  Hansel and Convey 
(1983) review the order of events pertaining to the feedback mechanism of LH.  First, LH binds 
to its receptor which is located in the plasma membrane.  This union activates adenylate cyclase 
and the production of cAMP occurs along with protein kinase activation.  Following this, 
steroidogenic enzymes undergo phosphorylation as well as increased protein synthesis.  Lastly, a 
segment of the bound LH is internalized and degraded, whereby secretory granules recycle LH 
receptors and incorporate them into the plasma membrane via exocytosis (Hansel and Convey, 
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1983).  Prior to ovulation, a preovulatory surge of LH and FSH occurs due to the positive 
feedback that increased concentrations of E2 have on the hypothalamus.  This positive feedback 
mechanism causes a surge in GnRH which then releases LH and FSH.  This surge in LH and 
FSH which typically lasts for 6 to 12 h is responsible for ovulation which occurs 24 to 30 h after 
peak gonadotropin levels (Hafez and Hafez, 2000).   
 During the preovulatory period, concentrations of E2 increase in both the ovarian venous 
blood (Baird and Scaramuzzi, 1976) and peripheral blood (Hansel et al., 1973), while reaching 
peak concentrations at estrus.  While P4 concentrations are decreased in the preovulatory period, 
the increase in E2 clearly initiates the surge of GnRH, hence the release of LH and FSH and, 
consequently, ovulation (Hansel and Convey, 1983).  In ewes, a preovulatory-like surge of LH is 
induced by the administration of exogenous E2 (Howland et al., 1971).   
 One of the most important hormones vital for a successful pregnancy in mammalian 
species is P4.  Progesterone is crucial in regulating the establishment and maintenance of 
pregnancy along with various other reproductive events including uterine and mammary gland 
development and the process of ovulation.  Additionally, P4 is integral for the implantation and 
maintenance of the embryo and inhibits smooth muscle contractions of the uterus (Leonhardt and 
Edwards, 2002). 
 Progesterone has a negative feedback on the hypothalamus.  Elevated P4 concentrations 
reduce the basal episodic secretion of GnRH, therefore inhibiting the development of 
preovulatory follicles, the production of E2, estrus behavior and the preovulatory surge of GnRH 
and LH.  The CL will maintain production of P4 throughout pregnancy if an embryo is present.  
Production of P4 by the CL begins approximately on d 4 thereby marking the beginning of 
diestrus.  Growth of the CL continues until maximal size and function has been obtained between 
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7 and 14 d.  If pregnancy is not established, structural and functional degradation of the CL 
occurs on d 15 or 16, thus initiating a new estrous cycle to begin (Bazer et al., 1998). 
 Functioning as an endocrine organ, the uterine endometrium is responsible for producing 
PG which is a vasoconstrictor that causes luteolysis, or degeneration, of the CL if pregnancy is 
not established between d 15 and 16 post-estrus (Bazer et al., 1998).  The main hormones 
responsible for the uterine release of PG are E2, P4, and oxytocin.  The release of oxytocin is 
mediated by P4 and E2 by regulating endometrial oxytocin receptor expression in the endothelial 
lining.  Synthesis of oxytocin is inhibited by P4 for 10 to 12 h and is known as the “progesterone 
block”.  Progesterone receptors decline though because the endometrium exhibits a negative 
feedback due to the continuous exposure to P4.  Estrogen is then synthesized by the epithelium 
of the endometrium and released as P4 receptors decline.  Oxytocin receptor expression is thus 
up-regulated due to the release of E2 and therefore the production and release of PG is achieved 
during the late luteal phase (Bazer et al., 1998).  Developing antibodies that destroy oxytocin 
inhibit PG secretion, thus decreasing the production of the PG and increasing the duration of the 
luteal phase (Senger, 2005).  Prostaglandin reaches the CL from the uterine vein by a vascular 
countercurrent exchange mechanism into the ipsilateral ovarian artery first suggested by 
McCracken et al. (1971).  A high proportion of PG, without being diluted in the circulatory 
system, is sure to reach the ovary through this unique anatomical structure (Senger, 2005).     
Controlled Reproduction in the Ewe 
Seasonality 
 Sheep are often referred to as “short day” breeders because they begin to cycle and 
become sexually responsive when the amount of darkness increases in late summer to early 
autumn (Robinson and Karsch, 1988).  The utilization of the photoperiod as a cue for breeding to 
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occur is especially prevalent and more relied upon by sheep that are managed in colder and 
temperate climates located at latitudes greater than 30˚ from the equator (Robinson and Karsch, 
1988; Lincoln, 1992; Rosa and Bryant, 2003).  In northern latitudes, sheep have been managed to 
breed in the fall, particularly mid-October through November in order to lamb in the spring or 
early summer (Robinson and Karsch, 1988).  Lambing is ideal during this time because maximal 
growth and development of the offspring can be achieved while meeting the demands of the 
mother during lactation, all of which can be supported by optimal natural environmental 
conditions and forage production (Wayne et al., 1989).  In a study conducted by Hulet et al. 
(1974) utilizing Rambouillet sheep, the estrous cycles of ewes located in the northwestern United 
States were compared to those of ewes in the southern United States.  This study reported that 
ewes in the northwest had a greater duration of natural anestrous when compared with southern 
ewes (Hulet et al., 1974).  Anestrous is a time during which the female is not receptive to being 
breed as she does not display a natural heat or exhibit regular estrous cycles during the spring 
and early summer months (Senger, 2005).         
 Photoperiod is one of the most important external factors that initiates the onset of the 
breeding season.  The duration of the photoperiod is perceived by the amount of light that 
reaches the photoreceptors located on the retina (Abecia, 2011).  Signals are then sent to a 
specific area of the rostral hypothalamus known as the suprachiasmatic nucleus (SCN) via a 
monosynaptic tract known as the retinohypothalamic tract.  By regulating endogenous circadian 
rhythms, the SCN functions as an internal biological clock.  The SCN is linked to the pineal 
gland by sympathetic innervation designated by the superior cervical ganglia (SCG; Lincoln, 
1992; Rosa and Bryant, 2003).  The pineal gland is responsible for facilitating the effects of 
photoperiod to bring about seasonal cyclicity by regulating the release of melatonin in a fashion 
 10 
 
that mimics a circadian rhythm.   The release of melatonin occurs only at night and is positively 
correlated with the duration of darkness (Arendt et al., 1988; Karsch et al., 1988; Abecia, 2011).  
Melatonin stimulates the release of GnRH from the tonic center initiating the pulsatile release of 
LH thus promoting cyclicity (Senger, 2005).       
Out-of-Season Breeding 
Lambing occurs primarily at one time of the year since sheep are seasonally polyestrus.   
Therefore, the supply of lamb is concentrated during one part of the year in which most lamb is 
sold and ready for market at the same time.  Due to the fluctuating availability of lamb, great 
variability in lamb prices occurs throughout the year, resulting in supply and demand of the 
season (National Research Council, 2008).  Most lambs are born during winter and spring 
months, weaned in the summer and fall, and harvested 60 to 120 d after a finishing period.  As a 
result, only a small portion of the U.S.’s lamb crop is born in the fall which creates a limited 
amount of fresh lamb for retail in the winter to early spring.  Hence, the price of lamb increases 
greatly during this time.  For producers to take advantage of this increase in out-of-season lamb, 
the industry needs to be able to effectively breed sheep during the anestrous season.  By doing 
so, consumers will be able to enjoy lamb products more continuously throughout the year while 
producers are able to take advantage of labor, facilities, and upward price trends as well.   
The Ram Effect  
Producers can effectively advance the breeding season by stimulating ewes into estrus 
and ovulation to occur during the non-breeding season, through the ram effect which is 
inexpensive and easily applied.  Anestrous ewes, isolated from rams for at least a month, will 
exhibit a synchronized heat after re-introduction to the male approximately one to one and a half 
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estrous cycles (17 to 24 d) later.  This phenomenon has been termed the ‘ram effect’ and was 
first observed in sheep in the early 1940’s (Underwood et al., 1944; Martin et al., 1986).   
 Some ewes may ovulate only once without visible estrus and then return to anestrous.  
Many ewes, though, ovulate twice without displaying estrus at each ovulation; however, if a CL 
develops in response to the second ovulation, the first fertile estrus is typically exhibited in 
conjunction with the third ovulation in response to the ram effect (Notter, 2002).  The first 
induced LH surge causes an ovulation to occur without detectable estrus within 2 to 3 d of ram 
exposure and is of low fertility.  If a CL does form from the first ovulation though, it typically 
regresses after 4 to 5 d.  Once regression has occurred, a second ovulation is induced and again 
no visible estrus is detectable.  For estrus to accompany an ovulation, it is necessary for the ewe 
to be exposed to appropriate progesterone/progestagen dosages to release the ewe from the 
endocrine systems inhibitory feedback during anestrous.  This ‘priming’ of the endocrine system 
needs to occur and once the body has been ‘primed’ short luteal phases will be prevented; hence, 
the CL will be able to be maintained for the full 14 d luteal phase (Schinckel, 1954; Martin et al., 
1986; Perkins and Fitzgerald, 1994).  The ram effect not only elicits a response through physical 
or visual contact but pheromones, produced by the ram that are present in the wool and/or wax of 
entire rams, can stimulate breeding activity in ewes transitioning out of anestrous (Watson and 
Radford,1960; Knight and Lynch, 1980). 
 Several variables exist when determining the impact the ram effect will have on anestrous 
ewes, one of those factors being the sexual behavior of the ram (Gordon, 1997).  In a study 
conducted by Perkins and Fitzgerald (1994) in California, it was reported that a significantly 
greater percentage of ewes exposed to rams exhibiting a high level of sexual activity ovulated 
when compared with ewes exposed to low-activity rams (95% vs. 78%, respectively).   
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 The current status of the female is another vital component in regulating how successful 
the ram effect is going to be in regards to how deep in anestrous she is at the time of ram 
exposure (Cushwa et al., 1992).  Response to the ram effect is greater in ewes as the start of the 
normal breeding season approaches.  Cushwa (1992) documented a greater percentage of ewes 
responded to the ram effect in June than in May at 92% and 80%, respectively. 
 The ram effect can also be used in conjunction with CIDR inserts to advance the breeding 
season and lambing.  In a study conducted by Wheaton et al. (1992), during the breeding season 
100% of ewes treated with a CIDR for 12 d exhibited estrus within 30 d after removal of the 
CIDR and 93% subsequently lambed from conception within the 30 d breeding period.  Of the 
59 ewes treated with a CIDR, 97% exhibited estrus within 3 d of CIDR removal and 51% 
lambed.  Of those ewes not treated with a CIDR, 95% exhibited estrus and 84% lambed within 
the 30 d period following CIDR withdrawal.  In the anestrous season of the same study, it was 
reported that 97% of ewes treated with a CIDR for 12 d exhibited estrus and 82% lambed from 
mating’s during the specified 30 d period after CIDR removal.  Of the 55 ewes treated with a 
CIDR, 89% exhibited estrus within 3 d of CIDR removal and 51% of those ewes lambed.  Of the 
control ewes, 100% displayed estrus within the 30 d breeding period following CIDR removal 
and 100% of those ewes lambed within the 30 d breeding period.   
Estrous Synchronization  
Progestins 
The primary role of P4, specifically when the female is pregnant, is to prevent the ewe 
from returning to estrus and ovulating.  Synthetic derivatives of P4 are used to stimulate P4 
production by the CL.   Therefore, when the source of P4 is removed, concentrations of P4 are 
reduced, causing luteolysis, hence priming the ewe to return to estrus.  Numerous methods are 
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available for the exogenous delivery of P4; the most common of those being through the use of 
an intravaginal device that slowly releases P4, or oral feed additives.      
Flurogestone Acetate and Medroxyprogesterone Acetate 
Since the 1960s, the traditional method for synchronizing estrus in small ruminants 
during the breeding and anestrous seasons has been through the use of polyurethane sponges.  
The two common, highly potent progestagens that sponges are often infused with are 
Flurogestone acetate (FGA, 17α-Acetoxy-9-fluoro-113-hydroxypregn-4-ene-3, 20-dione) and 
Medroxyprogesterone acetate (MAP, 17α-Acetoxy-6α-methylpregn-4-ene-3, 20-dione).  
Sponges are inserted vaginally in the ewe, remain in place for 12 d, and often a single dose of 
gonadotropin or pregnant mare serum gonadotropin (PMSG) is administered at removal of the 
device (Wildeus, 2000).  The appropriate dose level of FGA in sponges lies in the range of 20 to 
40 mg and for MAP sponges the dose level employed is generally around 40 to 60 mg.  Sponges, 
when inserted, should be placed as deep in the vagina as possible, up against the cervix with the 
sponge draw-strings clearly visible, for easy removal (Gordon, 1997 and 2004).   
A study was conducted in anestrous Awassi ewes to determine the most appropriate form 
of P4 treatment with a sponge.  Sponges were infused with 60 mg MAP, 30 mg FGA, and 40 mg 
FGA and remained in place for 12 d.  At sponge removal and injection of 600 International Units 
(IU) of PMSG was administered.  Husein and Kridli (2002) reported that all sponge applications 
(MAP, 30 mg FGA, 40 mg FGA and P4 sponges coupled with PMSG) were equally effective at 
inducing estrus.  Ewes detected in estrus and overall lambing rate was similar (P > 0.1) among 
all treatment groups.   
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Melengestrol Acetate 
Developed in 1962, Melengestrol acetate (MGA, 6-methyl-17-alpha-acetoxy-16 
methylene-pregn-4,6-diene-3,20-dione) is an orally active synthetic progestogen delivered via 
feed consumption and is used as a regimen for synchronizing estrus in sheep.  Not only is MGA 
appealing in that it is affordable; but, MGA also offers several properties that make it practical to 
use as a synchronization tool, for it has the ability to promote endometrial proliferation, maintain 
pregnancy, and delay estrus activity.  Although MGA was first marketed for the use in feedlot 
heifers to inhibit estrus, thereby improving feed efficiency and rate of gain, appropriate dosages 
have been adopted to control estrus and ovulation in seasonally anestrous ewes (Patterson et al., 
1989).   
The sheep industry has found that MGA fed typically at a rate of 0.125 mg MGA per day, 
can be fed either once (Jabbar et al., 1994) or twice (Saffranski et al., 1992; Powell et al., 1996; 
Morrical et al., 1997; Daniel et al., 2001) per day, just prior to breeding for a period of 8 to 14 d.  
One of the major drawbacks to the administration of MGA has been the documented reduction in 
fertility.  Ewe fertility has ranged from 48 to 61% of ewes coming into a synchronized estrus up 
to 10 d after the last feeding of MGA with the greatest fertility coming after only 4 d of treatment 
(Jabbar et al., 1994; Powell et al., 1996).   
In cattle, after the last feeding of MGA, the average interval to estrus or ovulation ranged 
from 3 to 7 d (Patterson et al., 1989).  In numerous studies involving cattle treatments utilizing 
progestagens reduced fertility at the estrus immediately after treatment, especially if fed for more 
than 14 d; however, not at any subsequent estrus that followed (Patterson et al., 1989).  Despite 
this concern, at the end of the regular breeding season, cattle on MGA treatment had pregnancy 
rates greater than or equal to controls (Patterson et al., 1989).  In contrast, Powell et al. (1996), 
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reported in sheep that the duration of feeding MGA (0.25 mg/ewe/d for 8, 11, or 14 d) did not 
affect the interval from the last feeding to estrus, the proportion of ewes lambing per ewe 
exposed, or lambs born per ewe lambing.  Melengestrol acetate can also be used in conjunction 
with gonadotropins (Saffranski et al., 1992; Jabbar et al., 1994; Powell et al., 1996; Morrical et 
al., 1997).              
Gonadotropins  
Gonadotropins are often coupled with P4 treatments aimed at synchronizing estrus to 
initiate ovulation and enhance fertility in anestrous ewes.  The most popular gonadotropin used is 
P.G. 600 (Wildeus, 2000).  Commercially available P.G. 600, which is only approved for the use 
in swine to induce estrus in pubertal gilts, contains 400 IU of equine chorionic gonadotropin 
(eCG) and 200 IU of human chorionic gonadotropin (hCG) per 5 mL and is often used in sheep 
at the 5 mL does level recommended for swine in combination with MGA treatment (Wildeus, 
2000).   
A variety of outcomes have been reported with the use of P.G. 600.  Safranski et al. 
(1992) documented that P.G. 600 when coupled with an MGA treatment lasting 10 d had no 
beneficial effects on conception rate and number of lambs born per ewe.  In contrast, when 5 mL 
of P.G. 600 was injected at the end of a 10 d MGA treatment, a 20% increase in conception rate 
was reported by Morrical et al. (1997) in ewes receiving the combination treatment and controls 
compared with ewes receiving MGA only.  Windorski et al. (2008) reported an increase in the 
percentage of ewes mated during the first 6 d of the breeding season in MGA and MGA + P.G. 
600 treated ewes when compared with control and the interval from ram introduction to lambing 
was decreased in MGA treated ewes (approximately 166 d) than control ewes (171 d).  In the 
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same study by Windorski et al. (2008), a greater proportion of ewes fed MGA (18%) lambed to a 
synchronized estrus when compared to control ewes (2.0%).   
P.G. 600 has been shown to increase ovulation rate in Hampshire, Rambouillet, and Finn-
Dorset-Rambouillet crossbred ewes from 1.79 CL/ewe in control ewes to 2.32 CL/ewe in ewes 
treated with MGA and P.G. 600; however, ewes receiving P.G. 600 only, had significantly 
reduced mating rates (6.6%) when compared to ewes receiving both MGA and P.G. 600 (69.8%, 
Safranski et al., 1992).  Ovulation rate can be increased through the administration of P.G. 600 
but it needs to be used in conjunction with a progestagen treatment to induce estrus in ewes.  
Prostaglandins 
Prostaglandins are vital in regulating reproduction in female livestock.  Prostaglandins 
play essential roles in ovulation, luteal function, maternal recognition of pregnancy, implantation 
and maintenance of gestation.  Exogenous prostaglandins have been used in conjunction with 
progestins, estrogens, and GnRH to assist in the synchronization of estrus (Weems et al., 2006).  
Prostaglandin increases pituitary responsiveness to GnRH to release LH (Randel et al., 1996) and 
the main role of PG during the estrous cycle is termination of the luteal phase through luteolysis.  
The ewe will return to estrus and ovulate after regression of the CL.  Prostaglandins therefore are 
only effective on cyclic females who have an active CL.  Prostaglandin can have an effect on the 
CL from d 4 of the estrous cycle to the day of natural luteolysis (Hackett and Robertson, 1980).  
Thus, it is ideal to administer 2 injections of PG, 9 to 10 d apart.  This will ensure that most of 
the ewes will be in mid-luteal phase at the time of the second injection and therefore will respond 
with estrus behavior and ovulation.  Hence, ewes in anestrous or in early or late luteal or 
follicular phase at the time of administration of PG will not respond (Abecia et al., 2011 and 
2012).  
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  In a study comparing the use of CIDRs coupled with a PG injection given twice, 3 h 
apart 1 d before CIDR removal or PG administered twice, 3 h apart after CIDR removal and PG 
administered alone, it was reported that ewes receiving a CIDR and PG together exhibited a 
greater estrus response, greater pregnancy rate to the first service, and a greater lambing rate to 
the first service period than those ewes receiving a PG injection alone (Dixon et al., 2006).  This 
illustrates that the use of PG along with a CIDR is more effective at bringing ewes into a 
synchronized estrus versus when used alone.   
Controlled Internal Drug Releasing Inserts  
The CIDR dates back to 1981 upon its development by the AHI Plastic Moulding 
Company, Hamilton, in conjunction with the Ministry of Agriculture & Fisheries in New 
Zealand (Wheaton et al., 1993).  A CIDR insert is composed of silicone molded over a flexible 
nylon spine with a tail protruding from the core and is infused with 0.3 g of exogenous P4  and is 
to be inserted vaginally (Wheaton et al., 1993).   
Intravaginal CIDRs are utilized on commercial sheep operations as a controlled 
reproductive management tool.  After withdrawal of the CIDR, a surge of gonadotropin from the 
AP is likely to occur and is sufficient to induce estrus at least 36 h after ram exposure and 
therefore a producer is able to synchronize their flock for the breeding season (Van Cleeff et al., 
1998).   
Traditional industry practice has been to insert a CIDR for 12 to 14 d (normal luteal 
phase) with or without an injection of gonadotropin at removal (Rhodes and Nathanielsz, 1988; 
Carlson et. al, 1989; Wildeus, 2000; Abecia and Gonzalez-Bulnes, 2012).  During the anestrous 
season an injection of gonadotropin is often administered at CIDR removal because sufficient 
amounts of gonadotropin appear to be unavailable to initiate the required preovulatory events 
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necessary to bring about estrus and ovulation (Gordon, 1997).  Serum P4 concentrations have 
been found to increase rapidly after CIDR insertion, levels peak after 3 d and serum 
concentrations of P4 begin to decline gradually thereafter (Ainsworth and Downey, 1986; 
Wheaton et al., 1993).  Hamra et al. (1986) reported similar findings after treatment with CIDRs 
for 13 d in which P4 concentrations increased to near maximum levels within 24 h, reached peak 
levels 4 d after insertion and then declined gradually.  Keeping in mind the CL produces P4 
throughout its lifespan (10 to 14 d); no treatment protocols are recommended over 14 d.  
However, some studies utilizing CIDRs for as few as 5 d have achieved similar results when 
compared to leaving the CIDR in for 12 to 14 d (Knights et al., 2001a and 2001b).  
It has been reported that ewes receiving a CIDR for 14 d, when compared with those 
treated with a MAP sponge, showed estrus earlier and with closer synchrony (Rhodes and 
Nathanielsz, 1988).  Of those ewes receiving CIDR treatment, 80% came into estrus 1 d after 
CIDR removal compared with 41% of ewes treated with a MAP sponge.  In contrast, Hamra et 
al. (1989) reported no significant differences were found between ewes treated with FGA 
sponges and a CIDR.   
Another study comparing CIDRs and MAP sponges that were in place for 12 d with an 
injection of eCG (500 IU) at removal of the pessary device, reported no differences in the 
percentage of ewes in detected estrus (93.3 and 100%) and the duration from the end of 
treatment to the onset of estrus (30.1 ± 7.6 h and 29.6 ± 5.6 h) in ewes treated with a CIDR or 
MAP sponge, respectively (Hashemi et al., 2006).  Godfrey et al. (1999) reported an estrous 
response of 100% and 94.4% in ewes treated with a CIDR or by a P4 sponge without eCG 
contrary to the findings in the previous study by Hashemi et al. (2006).   
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Many studies have shown the use of FGA and MAP sponges and CIDRs are relatively 
equally effective in synchronizing estrus; however, many producers prefer utilization of the 
CIDR.  The first reason is that it is not necessary to break the hymen prior to insertion of a 
CIDR, as it needs to be done if sponges are to be utilized.  This is a great advantage for it reduces 
the potential of infection and vaginal adhesions that may occur (Romano, 2004).  Additionally, 
vaginal mucous secretions are often released upon the removal of sponges and are accompanied 
by a potent, foul smell making sponges less aesthetically pleasing to handle when compared to 
CIDRs in which vaginal fluid discharge is reduced (Carlson et al., 1989, Romano, 2004). 
Wheaton et al. (1993) reported 74% of ewes treated with a CIDR to synchronize estrus 
during the breeding season, lambed within a 6 d period and another 20% lambed 16 d later.  
Daniel et al. (2000) found ewes treated with a CIDR for 8 d had decreased days to estrus and a 
greater percentage of CIDR treated ewes lambed at parturition when compared with control 
ewes.  During the breeding season, Carlson et al. (1989) reported when CIDRs were left in place 
for 12 d, 91% of ewes were bred 5 d post CIDR removal and 67% lambed in response to matings 
within 5 d.  Overall, 92% of ewes lambed in the current study, compared with the spontaneous 
fall breeding for these flocks (95%).   
In two studies by Knights et al. (2001a; 2001b), a 5 d CIDR treatment was found to 
stimulate an effective estrous response in seasonally anestrous ewes compared with control ewes.  
In another study conducted by Knights et al. (2003), approximately 72% of ewes treated with a 5 
d CIDR came into estrus.  A 51% pregnancy rate was obtained and a 58% and 80% lambing rate 
to the first service and both services were achieved, respectively.   These two studies helped 
validate and aid in the approval of CIDR inserts which were recently sanctioned for use in sheep 
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by the U.S. FDA in 2009 (FDA, 2009).  The label instructions state one CIDR is to be inserted 
vaginally per ewe for 5 d to induce estrus in anestrous ewes (FDA, 2009). 
Since research pertaining to the 5 d CIDR following the products approval in 2009 for 
use in commercial sheep operations is limited, the aims of the following experiments have been 
designed to determine the efficacy of the 5 d CIDR at inducing estrus during both the estrous and 
anestrous seasons and the impact these protocols have on ewe reproductive performance. 
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CHAPTER 2. ESTROUS SYNCHRONIZATION IN SHEEP USING GONADOTROPIN-
RELEASING HORMONE, PROSTAGLANDIN, AND CONTROLLED INTERNAL 
DRUG RELEASE INSERTS 
 Abstract 
The objective of this two year study was to evaluate the effects of combinations of 
controlled internal drug releasing (CIDR) inserts infused with progesterone (P4) in association 
with prostaglandin (PG), and gonadotropin-releasing hormone (GnRH) on the reproductive 
performance of Columbia and Hampshire ewes (n = 76 and 100, respectively) after 
synchronization of estrus during the transition period (August).  Ewes were randomly assigned to 
1 of 3 periods 1 week apart and then were randomly assigned to 1 of 4 treatments; 1) Untreated 
(U, n = 44); 2) 5 d CIDR (0.3 g P4) insert (C, n = 45); 3) 5 d CIDR and PG (dinoprost, 10 mg 
i.m.) at CIDR removal (P, n = 43); and 4) GnRH (gonadorelin, 0.02 mg i.m.) at CIDR insertion 
(remained in place for 5 d) and PG at CIDR removal (G, n = 44).  Rams equipped with marking 
harnesses were introduced at CIDR removal (d 0) and ewes were checked at 0800 h and 1700 h 
daily for breeding marks starting on d 0.  Blood samples were collected via jugular venipuncture 
on d -12, -5, 0, 1, 2, 3, 4, 5, 6, 8, 10, 11, 12, 14, 17 and 20.  Serum was analyzed for P4 
concentrations via radioimmunoassay (RIA).  Data collected included: days to estrus, days to 
lambing, percentage of ewes exhibiting estrus, pregnancy rate, lambing rate, and prolificacy.  A 
treatment × time interaction (P ≤ 0.05) was present for concentrations of P4.  Untreated ewes had 
greater (P ≤ 0.01) concentrations of P4 compared with C on d 3 and 4, C and G on d 5, and P and 
G on d 6.  Overall days to estrus were greater (P ≤ 0.01) in U (9.7 ± 1.12 d) and P (6.5 ± 1.05 d) 
compared with C (3.6 ± 1.03 d).  The proportion of ewes exhibiting estrus within 7 d post ram 
introduction, the first service period, was greater (P ≤ 0.01) in all treatments receiving a CIDR 
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compared with U.  Pregnancy rate within 7 d post CIDR removal was greater (P = 0.02) for C, P, 
and G (37%, 15 of 45; 36%, 15 of 43, and 28%, 12 of 44, respectively) compared with U (0%, 0 
of 44).   Lambing rate to the first service period was greater (P = 0.02) in C and P ewes 
compared with U, and G being intermediate.  No differences (P ≥ 0.17) were detected in 
pregnancy and lambing rate overall and prolificacy to the first and overall service periods.  In 
conclusion, all ewes receiving a CIDR treatment (C, P, or G) came into estrus more quickly than 
untreated ewes.  The proportion of ewes exhibiting estrus and pregnancy to the first service 
period was also greater in those ewes receiving any CIDR treatment compared with untreated 
ewes.      
Introduction 
In sheep, variability of hormone levels and time of ovulation occurs in females; hence 
efficacy in regards to various estrous synchronization protocols has been challenging to achieve 
(Dutt, 1953).  Several strategies for synchronization in sheep have included providing exogenous 
progesterone (P4) to extend the luteal phase or the administration of prostaglandin (PG) to 
shorten the luteal phase by causing regression of the corpus luteum (CL) (Wildeus, 2000).  In 
addition, estrus can be initiated in a portion of seasonally anestrous ewes after exposure to 
synthetic progestins and/or rams.  Effective ewe synchronization protocols could offer numerous 
advantages to both consumers and producers by production of a more continuous supply of lamb 
throughout the year and reduction of the overall breeding and lambing season(s) to reduce labor, 
feed, and facilities (Carlson et al., 1989). 
Current industry practice when using the controlled internal drug releasing (CIDR) insert 
as an estrous synchronization tool is to administer the insert for 12 to 14 d.  Some protocols also 
suggest an injection of gonadotropin after removal for improved estrus synchronization (Rhodes 
 23 
 
and Nathanielsz, 1988; Carlson et. al, 1989; Wildeus, 2000; Abecia and Gonzalez-Bulnes, 2012).  
In 2009, CIDR inserts were approved for use in sheep by the Food and Drug Administration 
(FDA) and labeled for 5 d to induce estrus in seasonally anestrous ewes (FDA, 2009).  
It has been reported that CIDR insertion for a 5 d period was equally effective at 
stimulating an estrus response in seasonally anestrous ewes compared with ewes treated with a 
12 d CIDR (Knights et al., 2001a).  Moreover, when the CIDR was used in combination with 
PG, a greater proportion of ewes were observed in estrus and a greater lambing rate to the first 
service period was achieved compared with ewes treated with PG alone (Dixon et al., 2006).  
Additionally, GnRH given prior to a 5 d treatment of exogenous P4 via a sponge and PG 
administered at removal was an effective synchronization protocol that improved prolificacy 
during the breeding season (Titi et al., 2010).  We hypothesized ewes receiving a 5 d CIDR 
treatment will express more synchronized estrus and have an increase in reproductive 
performance compared with untreated ewes.  The objective of the current study was to evaluate 
the effects of CIDRs administered for 5 d, GnRH, and PG on the reproductive performance of 
sheep during the transition period from anestrous to estrous. 
Materials and Methods 
The North Dakota State University Institutional Animal Care and Use Committee 
approved all procedures involving animals used in this research, IACUC #A11007.   
Experimental Design 
In August 2010 and 2011, at the North Dakota State University Sheep Unit in Fargo, ND, 
Columbia (n = 76) and Hampshire (n = 100) ewes were randomly assigned to treatment and 
period to examine estrus synchronization protocols applied to ewes prior to fall seasonal estrus 
cyclicity.  Three periods, 1 week apart, were used to control for effect of season.  One week prior 
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to treatment application, ewes were moved to paddocks that had not been previously grazed for 
one month.  Prior to treatment administration, all ewes were moved to a drylot and fed alfalfa 
hay (3 kg/ewe) and a 14% crude protein concentrate ration (1 kg/ewe) daily.   
Ewe estrous synchronization treatments were:  1) Untreated (U, n = 44); 2) 5 d CIDR 
insert  (EAZI-BREED CIDR Sheep Insert, 0.3 g P4, Pfizer Animal Health, New York, NY;C, n 
= 45); 3) 5 d CIDR and PG (Lutalyse, 10 mg/mL dinoprost tromethamine i.m., Pfizer Animal 
Health, New York, NY) at CIDR removal (P, n = 44); and 4) GnRH (Factrel, 0.02 mg/mL 
gonadorelin hydrochloride i.m., Pfizer Animal Health, New York, NY) at CIDR insertion and 
PG at removal (G, n = 43).  Ewes were single sire mated at a ewe to ram ratio equal to or less 
than 25:1.  Rams equipped with marking harnesses were introduced to ewes at CIDR removal (d 
0) and U ewes were also exposed to rams at this time.  Ewes were checked twice daily for 
breeding marks (detected estrus) at 0800 h and 1700 h starting on d 0.  Ewes remained with rams 
for at least 60 d. 
Blood Collection and Analysis   
To evaluate P4 concentration levels, blood samples were collected via jugular 
venipuncture into 10 mL serum tubes (BD Vacutainer Serum, Becton, Dickinson and Company, 
Franklin Lakes, NJ) and immediately placed on ice.  Samples were centrifuged at 4˚C for 30 min 
at 1,500 x g and serum was transferred into plastic 2.0 mL microcentrifuge tubes and frozen at -
20 ˚C until assayed.  Blood samples were collected 1 week prior to (d -12) and on the day of 
treatment initiation (d -5) to obtain baseline concentrations of P4.  Further samples were 
collected at CIDR removal (d 0) and on d 2, 4, 6, 8, 10, and 12 in 2010 and on d 1, 2, 3, 4, 5, 8, 
11, 14, 17, and 20 in 2011.  To detect circulating P4 in serum, samples were assayed using a 
solid-phase, no extraction RIA (Coat-a-Count Progesterone, Diagnostic Products Corporation, 
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Los Angeles, CA; Stevenson et al., 2011).  The assay kit was validated for ovine serum using an 
assay volume of 100 µl (Hamra et al., 1986; Schneider and Hallford, 1996).  Assay tubes for the 
standard curve contained 0.1, 0.25, 0.5, 1.0, 2.0, 5.0, 10.0, and 20 ng/ul.  Assay sensitivity for a 
100-µl sample was 0.1 ng/mL.  Ewes were determined to be cycling if serum P4 concentrations 
were greater than 1 ng/mL on either or both the d -12 or -5 samples.  All samples for a single 
ewe were ran within the same assay and treatments were run in a random order.  The intra- and 
inter-assay CVs were 5.39% and 3.61%, respectively.  
Reproductive Performance 
Data collected included:  days to estrus, days to lambing, percent ewes exhibiting estrus, 
pregnancy rate, lambing rate, and prolificacy.  The latter four measures of interest were classified 
as either to the first service period which is defined as 7 d post CIDR removal or overall 
beginning from d 0 until ram removal.  The number of ewes marked by a ram as a percentage of 
all ewes on study was represented by the percent of ewes exhibiting estrus.  The number of ewes 
lambing as a percentage of ewes in all treatments was denoted as pregnancy rate and the number 
of lambs born per ewe exposed to rams is represented by lambing rate.  Lastly, the number of 
lambs born per ewe lambing is represented as prolificacy.  
Statistical Analysis   
Repeated measures of the MIXED procedure of SAS (SAS Inst., Inc., Cary, NC) were 
used to analyze serum concentrations of P4.  Main effects of the model included treatment, time, 
cycling status, and treatment × time interaction.  The MIXED procedures of SAS were utilized to 
examine days to detected estrus and days to lambing.  The model included the main effects of 
treatment, breed, age cycling status, and all possible interactions.  The GLIMMIX procedures of 
SAS were used to analyze percent ewes exhibiting estrus, pregnancy rate, lambing rate, and 
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prolificacy.  The model included the main effects of treatment, breed, age, cycling status, and 
their respective interactions.  To compare all CIDR treatment groups against untreated ewes, 
contrast statements were run on days to estrus, days to lambing, percent ewes exhibiting estrus, 
pregnancy rate, lambing rate and prolificacy to both the first service period and overall.  Data are 
presented as least squares means and treatment differences were considered significant at P ≤ 
0.05.  Interactions with a P-value > 0.20 were removed from the model. 
Results 
Serum Concentrations of Progesterone  
A treatment × time interaction (P ≤ 0.05; Figure 2.1) was present for concentrations of 
P4.  At CIDR insertion (d -5), G had greater (P ≤ 0.01) concentrations of P4 compared with C 
and P.  All treatments receiving a CIDR insert had greater (P ≤ 0.01) concentrations of P4 at 
CIDR removal (d 0) compared with U.  Untreated ewes had greater (P ≤ 0.01) concentrations of 
P4 compared with C on d 3 and 4, C and G on d 5, and P and G on d 6.  On d 8, U had lower (P 
≤ 0.03) concentrations compared with C.  On d 12, U had lower concentrations of P4 compared 
with C, P, and G whereas P had greater (P ≤ 0.01) concentrations compared with C.  Lastly, on d 
17, U had greater (P ≤ 0.02) concentrations of P4 compared with P and G, and P had greater (P ≤ 
0.04) concentrations of P4 compared with C.        
Reproductive Performance Data 
Overall days to estrus after CIDR removal was greater (P ≤ 0.01; Table 2.1) in U (9.7 ± 
1.12 d) and P (6.5 ± 1.05 d) compared with C (3.6 ± 1.03 d) whereas G was intermediate (6.2 ± 
1.06 d).  Similarly, ewes receiving any CIDR treatment (C, P, or G, 6.52 + 1.06 d) expressed 
estrus sooner (P = 0.01) after ram introduction than untreated ewes (9.68 + 1.12 d).  Overall days 
to lambing were not different (P ≤ 0.01; Table 2.1) among the treatments.  Additionally, no 
 27 
 
differences (P ≤ 0.10) were detected for days to lambing in ewes receiving any of the CIDR 
treatments compared with untreated ewes.  The proportion of ewes exhibiting estrus during the 
first service period was the least (P = 0.01; Table 2.1) in U compared to all CIDR treated ewes; 
however, no differences (P = 0.17) were detected for percent ewes exhibiting estrus between 
CIDR treated ewes and untreated ewes during the entire breeding season.  Moreover, no 
differences (P > 0.34) were detected among CIDR treated ewes for estrus rate during the first 7 
days and the entire breeding season.  Pregnancy rate within 7 d post CIDR removal was greater 
(P = 0.02; Table 2.1) for ewes receiving a CIDR (32%, 42 of 132) compared with untreated ewes 
(0%, 0 of 44).  No difference (P ≥ 0.40) in pregnancy rate to the first service period was detected 
among C, G, and P treated ewes.  Lambing rate to the first service period was greater (P = 0.02; 
Table 2.1) in all CIDR treated ewes (33%, 43 of 132) compared to untreated ewes (0%, 0 of 44).  
No differences (P ≥ 0.31; Table 2.1) were detected among treatments for overall pregnancy rate, 
lambing rate, or prolificacy.  
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Figure 2.1.  Serum progesterone (P4) profiles before and after 5 d controlled internal drug 
release (CIDR) synchronization protocols administered during the transition period.  Treatments: 
U = untreated; C = CIDR inserted on d -5 and removed on d 0; P = 5 d CIDR and PG given at 
removal; G = GnRH given on d -5, 5 d CIDR and PG given at removal.  A treatment × day 
interaction was detected (P ≤ 0.05).  † = G had greater concentrations of P4 compared with C 
and P on d -5 (P ≤ 0.05).  ‡ = C, P, and G had greater concentrations of P4 compared with U on d 
0 and 12 (P ≤ 0.05).  * = C had lower concentrations of P4 compared with U on d 3 and 4 (P ≤ 
0.05).  ** = C and G had lower concentrations of P4 compared with U on d 5 (P ≤ 0.05).  ▼= P 
and G had lower concentrations of P4 compared with U on d 6 and 17 (P ≤ 0.05).  ▲= C had 
greater concentrations of P4compared with U on d 8 and 10 (P ≤ 0.05).  ♣ = C had greater 
concentrations of P4 compared with P on d 17 (P ≤ 0.05).           
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Figure 2.2. Cumulative percentages of ewes that exhibited estrus per total ewes treated during 
the transition period in the various treatment protocols:  U = untreated; C = CIDR inserted on d -
5 and removed on d 0; P = 5 d CIDR and PG given at removal; G = GnRH given on d -5, 5 d 
CIDR and PG given at removal. 
 
Figure 2.3. Cumulative percentages of ewes that lambed per ewes treated who were bred during 
the transition period to the various treatment protocols:  U = untreated; C = CIDR inserted on d -
5 and removed on d 0; P = 5 d CIDR and PG given at removal; G = GnRH given on d -5, 5 d 
CIDR and PG given at removal.    
0
20
40
60
80
100
120
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 >30
E
w
es
 e
x
h
ib
it
in
g
 e
st
ru
s/
ew
es
 t
re
a
te
d
, 
%
 
Days after ram introduction 
U
C
P
G
0
20
40
60
80
100
120
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 >30
E
w
es
 l
a
m
b
in
g
/e
w
e 
tr
ea
te
d
, 
%
 
Day of lambing season  
U
C
P
G
 30 
 
  
Table 2.1.  Reproductive performance of ewes after 5 d controlled internal drug releasing 
(CIDR) synchronization protocols administered during the transition period  
  
Treatment
1 
 
 
Contrasts
3
 
Variable U C P G 
 
 
SEM 
P-
value
2
 
CIDR vs 
Untreated 
P-value 
Days to estrus, d
4
 9.7
a
 3.6
c
 6.5
b
 6.2
bc
 1.12 0.01 0.01 
Days to lambing, d
5
 173 166 165 171 3.23 0.08 0.10 
Ewes exhibiting estrus, %
6
        
    First service period
7
 35
a
 85
b
 73
b
 71
b
 6.8 0.04 0.01 
    Overall 84 96 95 89 4.4 0.34 0.17 
Pregnancy rate, %
8
        
    First service period 0
a
 37
b
 36
b
 28
b
 6.3 0.06 0.02 
    Overall
 
72 76 73 78 6.6 0.89 0.64 
Lambing rate
9 
       
    First service period 0
a
  0.53
b
    0.58
b
 0.38
ab
 0.12 0.08 0.02 
 
   Overall 
 
1.24      1.13 1.20 1.13 0.13 0.88 0.56 
Prolificacy
10
        
    First service period  .      1.44 1.60 1.34 0.22 0.58 . 
    Overall 1.73      1.47 1.64 1.44 0.10 0.31 0.17 
abValues within the same row with different superscripts differ (P ≤ 0.05). 
1
Treatments:  U = untreated; C = CIDR inserted on d -5 and removed on d 0; P = 5 
d CIDR and PG given at removal; G = GnRH given on d -5, 5 d CIDR and PG 
given at removal with ram exposure starting on d 0. 
2
P-value for F-tests of the mean. 
3
All CIDR based treatments (C, P, and G) were compared to the untreated ewes (U) 
with a contrast statement.  
4
Days to estrus post ram introduction as indicated by marks from rams equipped 
with marking harnesses. 
5
Days to lambing post ram introduction.   
6
Number of ewes marked by a ram as a percentage of all ewes treated. 
7
First service period is defined as the first 7 d post CIDR removal. 
8
Number of ewes that lambed less than 155 d post CIDR removal expressed as a 
percentage of all ewes treated.   
9
Lambs born per ewe exposed.   
10
Lambs born per ewe lambing.  
 
 
Discussion 
Through the use of exogenous P4 the lifespan of the corpus luteum can be manipulated 
and aid in regulating estrus and ovulation (Hansel and Convey, 1983).  In the current study, prior 
to treatment initiation, most ewes (63%) were not fully cyclic as indicated by low P4 
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concentrations as indicated by a P4 serum concentration sample less than 1 ng/mL on either day -
12 or -5.  The CIDR provided exogenous P4 as evident by elevated P4 concentrations on d 0 in 
all CIDR treatment groups (Figure 2.1).  Consequently, serum P4 concentrations had decreased 
from 2.52, 3.08, and 2.81 ng/mL on d 0 to 0.43,  0.92, and 0.89 ng/mL after CIDR removal (d 1) 
for C, P, and G; respectively.  In contrast, untreated ewes had almost no change in P4 
concentrations (1.15 ng/mL on d 0 to 1.14 ng/mL on d 1).  These values support previous 
findings by Ainsworth and Downey (1986) who reported a gradual decline in plasma P4 
concentrations from 5.5 ng/mL to 1.7 ng/mL following CIDR removal.   
Overall, the CIDR treated ewes had lower concentrations of P4 for 6 days after CIDR 
removal compared with U.  This decrease in concentrations of P4 indicates that the ewes were 
either in anestrous, proestrus or estrus.      
Bartlewski et al. (1999) reported concentrations of P4 begin to increase between 3 and 7 
d after estrus and then reach peak concentrations at approximately d 12.  In the current study, all 
ewes treated with a CIDR follow this fluctuation in concentrations of P4 with concentrations 
rising around d 8 and plateauing at approximately d 10 to 12.  This peak in concentrations of P4 
is evident in the current study for all treatments receiving a CIDR had greater concentrations of 
P4 on d 12 compared with U.  It appears U ewes were receptive to the ram effect which is 
evident by delayed increase in P4 concentration compared to CIDR treated ewes.  This lag period 
was similar to Schinckel (1954), who reported a lag period of 14 days post ram introduction.                           
Days to estrus were reduced by 6 days in C treated ewes and by 3 days for all the 
remaining ewes receiving a 5 d CIDR treatment.  This is consistent with Wheaton et al. (1992) 
who reported a reduced interval to estrus in ewes treated with a CIDR compared with untreated 
ewes.  In the current study, no differences were detected in overall days to lambing in untreated 
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ewes (173 d) and ewes treated with a 5 d CIDR (167 d).  This however, is in agreement with Titi 
et al. (2010) who reported no differences in days to lambing between those ewes treated with an 
exogenous P4 source for 5 days (average 166 d) and control ewes (174 d).  Of all ewes treated 
with a 5 d CIDR insert included in the treatment protocol that exhibited estrus, a majority (80%) 
came into estrus within 7 d after ram introduction; whereas, only 43% (Figure 2.2) of untreated 
ewes came into estrus during this period.  This data is consistent to the findings reported by 
Knights et al. (2001a and 2001b) in which P4 treated ewes had a greater proportion of ewes 
marked by rams within the first 5 d after ram introduction compared with control ewes.  
Although no differences were observed in the percentage of ewes exhibiting estrus overall, the 
findings in the current study are in close agreement with a study by Wheaton et al. (1992) in 
which 95% of untreated ewes and 100% of ewes receiving a CIDR for 12 d exhibited estrus. 
In this study, all ewes treated with a 5 d CIDR showed an improvement in pregnancy and 
lambing rate during the first 7 days of ram introduction; however, overall pregnancy rates and 
lambing rates were not improved by CIDRs when compared with untreated ewes.  Moreover, we 
failed to detect any differences in overall pregnancy or lambing among treatment protocols.  This 
study is in agreement with two studies conducted by Knights et al. (2001a and 2001b) who 
reported similar results (0%) for pregnancy rate and lambing rate to the first service period in 
control ewes compared with ewes receiving a 5 d CIDR treatment.  Of the untreated ewes that 
lambed, 0% lambed within the first 7 d of the lambing season (Figure 2.3).  Of those ewes 
treated with a CIDR, only 27% lambed within the first 7 d of the breeding season and 76% 
lambed overall (Figure 2.3).  These findings are not in agreement with Carlson et al. (1989) and 
Knights et al. (2001a) who reported 74% and 60 to 70%, respectively, that were treated with P4, 
lambed within the first service period.  Titi et al. (2010) reported an increase in prolificacy in 
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ewes treated with GnRH and PG coupled with an exogenous P4 source which is in disagreement 
with the current study, in which no differences were detected in prolificacy to both the first 
service period and overall.  
Implications 
In the current study, any protocol containing a 5 d CIDR insert decreased overall days to 
detected estrus; however, days to detected estrus were reduced the most when a 5 d CIDR was 
used alone.  Surprisingly though, the use of a 5 d CIDR did not reduce overall days to lambing.  
Additionally, a greater proportion of ewes treated with a 5 d CIDR exhibited estrus to the first 
service period; however, there was no difference in the percentage of ewes exhibiting estrus 
overall.  A greater percentage of ewes treated with a 5 d CIDR protocol became pregnant and 
lambed to the first service period.  In regards to overall lambing rate and prolificacy, untreated 
ewes performed just as well reproductively as those ewes treated with a 5 d CIDR.  Therefore, 
our research found the current management practices recommended to induce ewes into estrus 
(flushing and ram exposure) were equally effective as utilization of the 5 d CIDR to induce ewes 
into estrus during the transition period.  More research still needs to be conducted to identify 
effective applications of the recently approved 5 d CIDR for its use on commercial sheep 
operations to enhance overall ewe reproductive performance.    
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CHAPTER 3. OUT-OF-SEASON REPRODUCTIVE PERFORMANCE OF EWES 
SYNCHRONIZED TO ESTRUS WITH VARIOUS FIVE-DAY CIDR PROTOCOLS 
Abstract 
The objective of this experiment was to evaluate the reproductive performance of ewes 
after synchronization to estrus with progesterone (P4) impregnated controlled internal drug 
releasing (CIDR) inserts in combination with gonadotropin-releasing hormone (GnRH) and 
prostaglandin (PG).  Dorset and Katahdin ewes (n = 61 and 17, respectively) were assigned 
randomly during the anestrous period (April) to 1 of 4 treatments: 1) Untreated (U; n = 16); 2) 5 
d CIDR (0.3 g P4) insert (C; n = 21); 3) 5 d CIDR and PG (dinoprost, 10 mg i.m.) at CIDR 
removal (P; n = 20); and 4) GnRH (gonadorelin, 0.02 mg i.m.) at CIDR insertion and PG at 
CIDR removal (G; n = 21).  Rams equipped with marking harnesses were introduced at CIDR 
removal (d 0) and ewes were observed at 0800 h and 1700 h daily for breeding marks starting on 
d 0.  Blood samples were collected via jugular venipuncture on d -12, -5, 0, 1, 2, 3, 4, 5, 8, 11, 
14, 17, and 20 relative to CIDR removal and analyzed for serum concentrations of P4 via 
radioimmunoassay (RIA).  Data collected included: days to estrus, days to lambing, percentage 
of ewes exhibiting estrus, pregnancy rate, lambing rate, and prolificacy.  A treatment × time 
interaction (P ≤ 0.05) was present for concentrations of P4.  Concentrations of P4 were 
decreased (P ≤ 0.04) in G compared with U on d 2.  On d 14, C and P had greater (P ≤ 0.03) 
concentrations of P4 and G tended (P = 0.06) to have greater P4 concentrations compared with 
U.  In contrast, concentrations of P4 on d 20 were greater (P ≤ 0.03) in U compared with C. Days 
to estrus after CIDR removal, as indicated by breeding marks, were greater (P ≤ 0.02) in U (6.5 ± 
1.05 d) and P (5.9 ± 0.88 d) compared with G (3.0 ± 0.88).  Pregnancy rate within 7 d post CIDR 
removal were similar (P = 0.57) in the current study for U, C, P, and G (30%, 5 of 16; 30%, 7 of 
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21; 35%, 7 of 20; and 51%, 11 of 21; respectively).  Similarly, no differences (P ≥ 0.32) were 
detected for pregnancy rate overall and lambing rate and prolificacy to the first service period 
and overall.  It appeared the 5 d CIDR alone or coupled with GnRH and PG improved estrus 
synchronization; however, reproductive performance was not improved by any of the 5 d CIDR 
protocols.  These results warrant further research to determine the efficacy of industry-wide 
application of the 5 d CIDR in anestrous ewes.                              
Introduction 
Controlled internal drug releasing (CIDR) inserts were approved for use in sheep by the 
U.S. Food and Drug Administration (FDA) in 2009.  Prior to approval, common industry 
practice was to insert a CIDR for 12 to 14 d with or without an injection of gonadotropin at 
removal (Rhodes and Nathanielsz, 1988; Carlson et. al, 1989; Wildeus, 2000; Abecia and 
Gonzalez-Bulnes, 2012).  The current label recommendation is to insert one CIDR per ewe for 5 
d with the intention of inducing estrus in ewes during the anestrous season (FDA, 2009).  Use of 
the CIDR as a synchronization tool could benefit sheep producers by condensing the lambing 
season and reducing labor, feed, and facility costs. Producers strategically selling lamb during 
ethnic holidays and ‘out-of-season’ can take advantage of increased lamb prices at these times.  
In addition, uniform lamb crops are easier to manage and market (Carlson et al., 1989).     
In two studies by Knights et al. (2001a; 2001b), a 5 d CIDR treatment was found to 
stimulate an effective estrus response in seasonally anestrous ewes compared with untreated 
ewes.  Addition of a prostaglandin (PG) injection at CIDR removal elicited a greater percentage 
of ewes observed in estrus and a greater lambing rate to the first service period compared with 
ewes treated with PG alone (Dixon et al., 2006).  Moreover, in a recent study, Titi et al. (2010) 
reported improvements in estrous synchronization and prolificacy with the inclusion of an 
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injection of GnRH prior to insertion and PG at removal of intravaginal P4 sponges for 5 d during 
the breeding season.  Limited research has been conducted utilizing the 5 d CIDR in combination 
with GnRH and PG in seasonally anestrous ewes.  Therefore, we hypothesized ewes receiving a 
CIDR coupled with GnRH and PG treatment would display a more synchronized estrus when 
compared with untreated ewes.  The objective of this study was to determine the efficacy and 
reproductive performance of ewes during the anestrous season after synchronization to estrus 
with P4 impregnated CIDR inserts in conjunction with GnRH and PG. 
Materials and Methods 
All procedures involving animals used in this research were approved by the North 
Dakota State University Institutional Animal Care and Use Committee, IACUC #A11007.   
Experimental Design 
In April 2011, during the anestrous period, multiparous and nulliparous Dorset and 
Katahdin (n = 61 and n = 17, respectively) ewes from the North Dakota State University Sheep 
Unit in Fargo, ND, were randomly assigned to 1 of 4 treatments:  1) Untreated (U, n = 16); 2) 5 d 
CIDR insert (EAZI-BREED CIDR Sheep Insert, 0.3 g P4, Pfizer Animal Health, New York, 
NY), inserted on d -5 (C, n = 21); 3) 5 d CIDR and PG (Lutalyse, 10 mg/mL dinoprost 
tromethamine i.m., Pfizer Animal Health, New York, NY) at CIDR removal (P, n = 20); and 4) 
GnRH (Factrel, 0.02 mg/mL gonadorelin hydrochloride i.m., Pfizer Animal Health, New York, 
NY) given at 5 d CIDR insertion and PG at CIDR removal (G, n = 21).  Prior to treatment 
application, ewes were managed as a common group in a dry lot and isolated from all males.  
Once treatments were initiated, ewes had ad-libitum access to alfalfa hay and had continuous 
access to fresh water.  Four intact rams were equipped with marking harnesses and introduced to 
ewes immediately post CIDR removal with a ewe to ram ratio not exceeding 25:1.  Ewes were 
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observed for breeding marks (detected estrus) twice daily at 0800 h and 1700 h and ewes 
remained with rams for 42 d.   
Blood Collection and Analysis  
Blood samples were collected via jugular venipuncture into 10 mL serum tubes (BD 
Vacutainer Serum, Becton, Dickinson and Company, Franklin Lakes, NJ) on d -12, -5, 0, 1, 2, 3, 
4, 5, 8, 11, 14, 17, and 20 relative to CIDR removal (d 0).  Samples were immediately placed on 
ice for 2 h prior to centrifugation, centrifuged at 4˚C for 30 min at 1,500 × g and serum was 
transferred into plastic 2.0 mL microcentrifuge tubes and frozen at -20 ˚C until assayed.  Serum 
samples were assayed for circulating P4 using a solid-phase, no-extraction RIA (Coat-a-Count 
Progesterone, Diagnostic Products Corporation, Los Angeles, CA; Stevenson et al., 2011).  The 
assay kit was validated for ovine serum using an assay volume of 100 µl (Hamra et al., 1986; 
Schneider and Hallford, 1996).  Assay tubes for the standard curve contained 0.1, 0.25, 0.5, 1.0, 
2.0, 5.0, 10.0, and 20 ng/ul.  Assay sensitivity for a 100-µl sample was 0.1 ng/mL.  Ewes were 
determined to be cycling if serum P4 concentrations were greater than 1 ng/mL in either or both 
the d -12 or -5 samples.  All samples for a single ewe were analyzed within the same assay and 
treatments were run in a random order.  The intra- and inter-assay CVs were 2.28 and 2.21%, 
respectively. 
Reproductive Performance  
 Data collected included:  days to estrus, days to lambing, percent ewes exhibiting estrus, 
pregnancy rate, lambing rate, and prolificacy.  The number of ewes marked by a ram as a 
percentage of all ewes on study was represented by the percent of ewes exhibiting estrus.  
Pregnancy rate was defined as the number of ewes lambing as a percentage of ewes in all 
treatments and the number of lambs born per ewe exposed to rams is represented by lambing 
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rate.  Lastly, prolificacy was the number of lambs born per ewe lambing. These components 
were classified as either to the first service period which was 7 d post CIDR removal or overall 
beginning from d 0 until rams were removed at d 42.       
Statistical Analysis   
Repeated measures of the MIXED procedure of SAS (SAS Inst., Inc., Cary, NC) were 
used to analyze serum concentrations of P4.  The model included the main effects of treatment, 
time, cycling status, and treatment × time interaction.  Days to detected estrus and days to 
lambing were examined using the MIXED procedures of SAS.  Effects of the model included 
treatment, breed, age, cycling status, and all possible interactions.  Percent ewes exhibiting 
estrus, lambing rate and prolificacy were analyzed using the GLIMMIX procedures of SAS.  The 
model included the main effects of treatment, breed, age, cycling status, and their respective 
interactions.  Contrast statements were run to compare all CIDR treatment groups against 
untreated ewes for days to estrus, days to lambing, percent ewes exhibiting estrus, pregnancy 
rate, lambing rate and prolificacy to both the first service period and overall.  Data are presented 
as least square means and treatment differences were considered significant at P ≤ 0.05.  
Interactions with a P-value > 0.20 were removed from the model. 
Results 
Serum Concentrations of Progesterone 
A treatment × time interaction (P ≤ 0.05, Figure 3.1) for concentrations of P4 was 
detected.  Concentrations of P4 were lower (P ≤ 0.04) in G compared with U on d 2.  No 
differences were detected (P = 0.64) among treatments in P4 concentrations.  After d 14, serum 
P4 concentrations of ewes in the U treatment increased to levels similar to all other treatments (P 
> 0.10; Figure 3.1).  On d 14, C and P had greater (P ≤ 0.03; Figure 3.1) concentrations of P4 
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and G tended (P = 0.06) to have greater P4 concentrations compared with U.  In contrast, 
concentrations of P4 on d 20 were greater (P ≤ 0.03) in U compared with C. 
Reproductive Performance Data 
All ewes treated with a CIDR exhibited estrus in less days post ram introduction (P = 
0.04; Table 3.1) than the untreated ewes.  Among treatments, G and C treated ewes exhibited 
estrus in less days (P < 0.02) than U treated ewes; whereas, P treated ewes did not differ (P = 
0.07) from U treated ewes.  Furthermore, G treated ewes exhibited estrus in less days (P = 0.02) 
than P treated ewes.  No differences (P = 0.55; Table 3.1) were detected among ewes for days to 
lambing.  No differences were detected (P ≥ 0.32; Table 3.1) among treatments for percentage of 
ewes exhibiting estrus to the first service period and overall.  Pregnancy rate to the first service 
period, 7 d post CIDR removal, were similar (P = 0.57; Table 3.1) in the current study for U, C, 
P, and G (30%, 5 of 16; 30%, 7 of 21; 35%, 7 of 20; and 51%, 11 of 21, respectively).  No 
differences (P ≥ 0.36; Table 3.1) were observed among treatments for overall pregnancy rate and 
lambing rate.  Similarly, no differences (P > 0.36) were detected for prolificacy to the first 
service period and overall.  
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Figure 3.1.  Serum progesterone (P4) profiles before and after 5 d controlled internal drug 
releasing (CIDR) synchronization treatment protocols administered during the anestrous season.  
Treatments:  U = untreated; C = CIDR inserted on d -5 and removed on d 0; P = 5 d CIDR and 
PG given at removal; G = GnRH given on d -5, 5 d CIDR and PG given at removal.  A treatment 
× time interaction was detected (P ≤ 0.05).  ▲ = U had greater concentrations of P4 compared 
with G on d 2 (P ≤ 0.05).  ‡ = C and P had greater P4 concentrations compared with U on d 14 
(P ≤ 0.05).  * = C had lower concentrations of P4 compared with U on d 20 (P ≤ 0.05).    
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Figure 3.2. Cumulative percentages of ewes that exhibited estrus per total ewes treated during 
the anestrous season in the various treatment protocols:  U = untreated; C = CIDR inserted on d -
5 and removed on d 0; P = 5 d CIDR and PG given at removal; G = GnRH given on d -5, 5 d 
CIDR and PG given at removal. 
 
 
 
Figure 3.3. Cumulative percentages of ewes that lambed per ewes treated who were bred during 
the anestrous season to the various treatment protocols:  U = untreated; C = CIDR inserted on d -
5 and removed on d 0; P = 5 d CIDR and PG given at removal; G = GnRH given on d -5, 5 d 
CIDR and PG given at removal. 
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Table 3.1.  Reproductive performance of ewes after 5 d controlled internal drug releasing (CIDR) 
synchronization protocols administered during the anestrous season   
  
Treatment
1 
 
 
 
Contrast s
3 
Variable U C P G 
 
 
SEM P-value
2
 
CIDR vs 
Untreated 
P-value 
Days to estrus, d
4
 6.5
a 
 3.4
bc
  5.9
ac
 3.0
b
  1.05 0.02 0.04 
Days to lambing, d
5
 152 152 154 150 2.99 0.55 0.95 
Ewes exhibiting estrus, %
6
        
    First service period
7
 63 70 65 92 0.11 0.32 0.39 
    Overall 94 82 100 96 0.07 0.34 0.86 
Pregnancy rate, %
8
        
    First service period 30 30 35 51 0.12 0.57 0.60 
    Overall
 
42 39 55 58 0.12 0.59 0.56 
Lambing rate
9 
       
First service            
period 0.36  0.42 0.55 0.64 0.18 0.65 0.44 
 
   Overall 
 
0.47 0.51 0.85 0.71 0.18 0.47 0.36 
Prolificacy
10
        
    First service period  1.22 1.45 1.38 1.19 0.22 0.70 0.64 
    Overall 1.15  1.31 1.55 1.24 0.19 0.44 0.36 
abValues within the same row with different superscripts differ (P ≤ 0.05). 
1
Treatments:  U = untreated; C = CIDR inserted on d -5 and removed on d 0; P = 5 
d CIDR and PG given at removal; G = GnRH given on d -5, 5 d CIDR and PG 
given at removal with ram exposure starting on d 0. 
2
P-value for F-tests of the mean. 
3
All CIDR based treatments (C, P, and G) were compared to the untreated ewes 
(U) with a contrast statement.   
4
Days to estrus post ram introduction as indicated by marks from rams equipped 
with marking harnesses. 
5
Days to lambing post ram introduction. 
6
Number of ewes marked by a ram as a percentage of all ewes treated. 
7
First service period is defined as the first 7 d post CIDR removal. 
8
Number of ewes that lambed less than 155 d post CIDR removal expressed as a 
percentage of all ewes treated.   
9
Lambs born per ewe exposed.   
10
Lambs born per ewe lambing.  
 
 
Discussion 
In the present study, as expected, all treatments receiving a 5 d CIDR insert showed 
numerically elevated concentrations of P4 at CIDR removal compared with U ewes.  The 
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reduction in concentrations of P4 from d 0 to d 2, suggests decreased luteal activity which may 
lead to a more uniform synchronization to estrus.  It appears, the administration of GnRH 5 d 
prior to CIDR insertion and PG at CIDR removal potentially induced ovulation and/or caused 
luteinization of the dominant follicle which is evident by the decreased concentrations of P4 in G 
compared with U on d 2, thus indicating more ewes were potentially in estrus within 48 hr post 
CIDR removal.  Prior to treatment initiation, a majority (62%) of ewes were classified as cycling 
as indicated by a P4 serum concentration sample greater than 1 ng/mL on either or both d -12 or 
-5.  In contrast, only 37% of ewes in Experiment 1 were cycling prior to CIDR insertion.  
Cyclicity during the anestrous season is not uncommon for the Dorset and Katahdin breed; 
however, since the overall pregnancy rate (42%) for U ewes was numerically lower than the 
cycling rate (62%), perhaps the ewes were not fully cyclic.  It has been documented that a semi-
cyclic pattern in ovarian activity is evident during early and late anestrous ewes (Cole and Miller, 
1935).  Although no differences were detected among treatments in concentrations of P4, the U 
treated ewes, had a mean P4  concentration of 3.35 ng/mL on d 0 followed by decreased P4 
concentrations on d 4 to 1.40 ng/mL (Figure 3.1).  The decrease in P4 concentrations may have 
been a result of a short cycle, where the corpus luteum (CL) develops a shorter than normal 
lifespan or the follicular phase induced by the first exposure to the ram was too short (Martin et 
al., 1986).  Perhaps ram introduction stimulated cyclicity in the U group and they developed a 
functional CL to produce similar quantities of P4 compared with the other treatments.  These 
results are consistent with Martin et al. (1986), who reported that after 6 d of the short cycle, a 
second ovulation is induced followed by a fertile cycle of normal length. This apparent effect of 
ram introduction provides justification that a majority of the ewes were either non-cyclic or 
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semi-cyclic.  After d 14, serum P4 concentrations of ewes in the U treatment increased to levels 
similar to all other treatments.   
All ewes treated with a 5 d CIDR incorporated into the designated treatment protocols 
came into estrus approximately 3 d earlier than those ewes not treated with a CIDR (Table 3.1).  
The C and G treated ewes came into estrus more quickly post ram introduction than the P treated 
ewes and the untreated ewes.  This data suggests C and G treated ewes displayed a tighter 
synchrony to estrus.  Wheaton et al. (1992) also observed ewes treated with a CIDR having a 
reduced interval to estrus compared with U ewes.  In the current study, no differences were 
detected in overall days to lambing among treatment groups as well as all ewes receiving a 5 d 
CIDR compared with untreated ewes.  This is in disagreement with Knights et al. (2001a), who 
reported 42% of anestrous ewes treated with a 5 d CIDR lambed (approximately 12 to 13 d) 
earlier than untreated ewes (165 d; Table 3.1).  Similar to  Knights, et al. (2001a), Wheaton, et al. 
(1993), reported ewes in anestrous who were treated with a CIDR for 12 d took fewer days (157 
± 2 d) to lamb post ram introduction compared with control ewes (170 ± 2 d).  The majority of 
ewes treated with a CIDR that exhibited estrus came into estrus within 7 d after ram introduction 
(86%) compared with U ewes (64%; Figure 3.2).  Even though no differences were detected 
among treatments for percentage of ewes exhibiting estrus to the first service and overall, in a 
study by Wheaton et al. (1992), the percentage of untreated ewes (95%) exhibiting estrus overall 
and those receiving a CIDR insert for 12 d (100%) were similar to the percentage of untreated 
ewes exhibiting estrus overall (94%) in the current study.  In two separate reports, Knights et al. 
(2001a, 2001b) reported a greater proportion of P4 treated ewes were marked by rams compared 
with control ewes.   
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Pregnancy rate within 7 d post CIDR removal were similar in the current study for U, C, 
P, and G (30%, 5 of 16; 30% , 7 of 21; 35%, 7 of 20; and 51%, 11 of 21; respectively).  In 
contrast, Knights et al. (2001a, 2001b) documented greater pregnancy rates to the first service 
period and an increase in lambing rate (Knights, 2000) in P4 treated ewes compared with control 
ewes.  Although no differences were observed among treatments for lambing rate and prolificacy 
in the current study, the majority of ewes treated with a CIDR that lambed, did so during the first 
7 d (74%; Figure 3.3).  A similar pattern of lambing was reported by Carlson et al. (1989); in 
their study, 74% of ewes treated with P4 lambed within 6 d.   Knights et al. (2001) also reported 
that 60 to 70% of ewes treated with P4 that lambed, did so during the first 8 d.  In the current 
study, only 31% (Figure 3.3) of untreated ewes lambed within the first 7 d of the lambing season 
compared with 42% of all ewes treated with a 5 d CIDR.  In contrast to the current study, Titi et 
al. (2010) reported an increase in fecundity in ewes treated with exogenous P4 when coupled 
with the use of GnRH and PG.  Although no differences were detected among reproductive 
performance data, this study suggests that C and G treatments were more effective at 
concentrating estrus shortly after CIDR removal compared with U and P treatments.        
Implications 
In the current study, the recently approved sheep CIDR which is recommended to be used 
for 5 days during the anestrous period, when used alone was not effective in generating 
synchronization results desired by most commercial sheep producers.  However, when the 5 d 
CIDR was coupled with GnRH and PG, estrus synchronization was improved in ewes by 
decreasing the overall days to estrus when compared with untreated ewes during the anestrous 
season.  Unfortunately though, the 5 d CIDR, regardless of what protocol it was incorporated 
into did not influence reproductive performance.  The efficacy of CIDR protocols to synchronize 
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estrus and improve fertility during the anestrous period was not clearly demonstrated in this 
study and more research is needed prior to recommendation of the 5 d CIDR in the commercial 
sheep industry. 
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CHAPTER 4. SUMMARY AND CONCLUSIONS 
 Producers rely greatly on the reproductive success of their flock in terms of the frequency 
of lambings that occur each year as well increasing the number of lambs born per ewe lambing in 
order to remain competitive and to ensure their livelihood in the future.  Sheep are known for 
their seasonality, in which they typically breed in the fall and lamb in the spring.  For producers 
to get more than one lambing in per year, ewes need to breed during the anestrous season.  
Through the development of advanced reproductive tools and recent approval by the Food and 
Drug Administration (FDA) of controlled internal drug release (CIDR) inserts for the use in 
sheep in the United States (U.S.), out-of-season breeding is becoming more of a reality than ever 
before. 
 To our knowledge, these experiments are the first to look at serum concentrations of 
progesterone (P4) in ewes treated with various 5 d estrus synchronization protocols that utilize a 
CIDR infused with P4 alone or coupled with either prostaglandin (PG) and gonadotropin-
releasing hormone (GnRH).  This study showed the 5 d CIDR decreased overall days to estrus 
(3.6 d) the most for ewes bred during the transition season when compared with untreated (9.7 d) 
ewes.  It was reported in a study by Glimp (1971) that Hampshire and Rambouillet ewes took on 
average 17.7 ± 1.5 d and 12.6 ± 1.5 d to come into estrus to the first service period which is close 
to the results of the similar study (9.7 d).  During the anestrous season, ewes receiving GnRH 
prior to CIDR insertion and PG at removal had the least days to detected estrus (3.4 d) overall 
when compared with untreated ewes (6.5 d).  By reducing the days in which sheep are bred, 
ideally the overall breeding and lambing seasons will be condensed, thereby enhancing the 
opportunity for producers to reduce labor costs associated with lambing, produce a more 
consistent lamb crop, and potentially engage in an accelerated lambing program.     
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 Not only are producers concerned with and strive for maximal number of lambs born per 
ewe lambing, but they also aim to reduce the number of days in the breeding season.  In the 
current study, reproductive performance in regards to pregnancy rate, lambing rate, and 
prolificacy to both the first service period and overall were not affected by any of the treatment 
protocols that utilized a 5 d CIDR.  Untreated ewes appeared to respond considerably well to the 
ram effect, although not statistically significant, for they displayed  an increase in the percentage 
of ewes in estrus, pregnancy rate and lambing rate from the first service period to overall, 
especially during the transition season.  Prolificacy in the untreated ewes was numerically greater 
than all treatments receiving a CIDR in Experiment 1, although this was not statistically 
significant.  Reproductively, it appears the untreated ewes performed just as well as their 
contemporaries.     
 Collectively, our study would suggest that producers can expect to see comparable 
reproductive results in ewes treated with a 5 CIDR alone or when coupled with various hormonal 
treatments when compared to those ewes not treated at all.  However, through the use of CIDRs, 
producers can decrease overall days to detected estrus.  Perhaps a more cost effect approach 
would be to use teaser rams to induce the ram effect on ewes.  Therefore, producers would need 
to advance the turn-out of teasers by two weeks in order to stimulate the ewes into estrus and to 
exhibit a fertile estrus at the desired date of ram turn out.  Much research still needs to be 
conducted utilizing the 5 d CIDR coupled with various hormonal treatments to truly determine 
the efficacy of the 5 d CIDR, along with establishing potential universal synchronization 
protocols that commercial sheep operations can follow and implement into their current breeding 
programs.       
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